NANJING, China and SINGAPORE/2021 /PRNewswire/ — GenScript ProBio, Suzhou Abogen Biosciences Technology Co. and Walvax Biotechnology Co. announced a collaboration on commercial manufacturing of an mRNA vaccine project (“ABO-028M”). Walvax Biotechnology will submit a BLA of the ABO-028M project and GenScript ProBio will provide exclusive services for the commercial manufacturing